ZLB BEHRING ANNOUNCES AVAILABILITY OF HUMATE-P WITH SMALLER DILUENT
ZLB Behring today announced that Humate-P (Antihemophilic Factor/von Willebrand
Factor Complex (Human), Dried, Pasteurized) is now available featuring a smaller
diluent — 50 percent less in all assay sizes. The new formulation, which
bears the current safety and efficacy profile of Humate-P, offers added convenience
to patients, healthcare professionals, and caregivers who administer Humate-P.
Humate-P is the only factor concentrate approved by the U.S. Food & Drug
Administration for use in treating adult and pediatric patients who experience
spontaneous and trauma-induced bleeding episodes in severe von Willebrand Disease
(VWD), and in mild or moderate VWD where the use of desmopressin is known or
suspected to be inadequate.
PR
Newswire
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May